Tibet Rhodiola Pharmaceutical Holding Co.SSE: 600211

(600211)"Tibet Rhodiola Pharmaceutical Holding Co., Ltd."Report for Q3 2026

· Issued by Tibet Rhodiola Pharmaceutical Holding Co. via Shanghai Stock Exchange

Filed with SSE · Stock code 600211 · · 18 pages · Chinese

Summary by 6ix AI

The report confirms the accuracy and completeness of the financial information presented, with the board of directors assuming legal responsibility for its content. The report also highlights the establishment of a joint venture aimed at expanding the company's market presence and product offerings.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Tibet Rhodiola Pharmaceutical Holding Co. on 6ix

Earlier from Tibet Rhodiola Pharmaceutical

Later from Tibet Rhodiola Pharmaceutical

All Tibet Rhodiola Pharmaceutical news releases